Oedème maculaire et occlusions veineuses

Etude LOUVRE et son incidence en pratique clinique

Par Jean-François KOROBELNIK

Le 16 juillet 2017

In the French clinical setting, DEX implant demonstrated efficacy and safety similar to those of phase 3 trials.

  • BCVA significantly increased at all follow-up visits
  • CRT was reduced at all follow-up visits
  • DEX implant was well tolerated
  • The most frequently reported AEs were cataract and IOP increase, consistent with previous observations


Consulter la synthèse et les résultats de l’étude publiés par Jean-François Korobelnik

Étiquettes : , ,